Myogenesis (Homo sapiens)

From WikiPathways

Jump to: navigation, search
910, 113, 4137, 81, 2, 5, 6, 12nucleoplasmcytosolp38alpha/beta/gamma:ABL1:JLP:CDO complexSPAG9 NEO1 SPAG9 CDON GTP MAPK11 BOC-1 CTNNB1 CTNNA2 CDH4 MEF2D BNIP2 Cadherin-catenin:CDO:BOC:Bnip2CTNNB1 ABL1 BOC-1 CDC42 CDH15 p-T312,T319-MEF2A ABL1:JLP:CDO complexMYF6 p-T183,Y185-MAPK12 p-T180,Y182-MAPK14 MEF2B Trans-cadherinhomodimersGTP CDH4 MEF2B CDH2 p-S207,T211-MAP2K6BNIP2 p-T293,T300,T387-MEF2C CDH4 TCF4 BOC-1 CDC42 CDH4 CDH2 p-S139-TCF3 p-T312,T319-MEF2A CDON CDH2 BOC-1 p38 MAPKalpha/beta/gammaMYOG MYF6 SPAG9CDH2 CDON CDON p-T180,Y182-MAPK11 MEF2B MEF2D CTNNA2 MEF2B BNIP2CDC42 CTNNB1 p-T180,Y182-MAPK11 CDON BNIP2 ABL1GTP CTNNA1 CTNNA2 CDH2 MEF2 proteinsCDH4 CDH2 CDH15 ATPNetrin-3:NeogeninNEO1 phospho-p38alpha/beta/gammaMAPKp-T293,T300,T387-MEF2C CDC42 MYF5 phospho-E proteinsCDON p-T180,Y182-MAPK14 ABL1 phospho-MEF2proteinsCTNNA1 CDH4 NTN3 MAPK12 TCF3CTNNA1 CDH2 CTNNB1 BNIP2 MAPK14 CDH15 MEF2A TCF12 BOC-1 MYOD1 MAPK12 NTN3 CDC42:GTPCDC42 CDH15 BNIP2 CDH4 SPAG9 MEF2D GTP CTNNA1 MAPK12 CTNNA2 MYF6 CTNNA1 pp38alpha/beta/gamma:ABL1:JLP:CDO complexMYOD1 BOC-1CTNNA1 ABL1 GTP Cadherin-catenin:CDO:BOC:Bnip2:CDC42-GTPCDC42 GTP p-T293,T300,T387-MEF2C BOC-1 MYOG CDH15 CDH15 p-T180,Y182-MAPK11 ATPTCF4 MyoD:phospho-E:phospho MEF2p-S139-TCF3ADPCDO:BOC:Neogenin:Netrin-3Cadherin-catenin:JLP:CDO:BOC:Bnip2-Cdc42MAPK14 CDH4 CDO:BOCMYOD1 phospho p38:phosphoMEF2MRFsTCF12 TCF12 BOC-1 CDO:BOC:Trans-cadherin homodimer:cateninMyod:phospho-EheterodimersMYOG CDH2 BNIP2 CTNNA2 BOC-1 MAPK11 p-T312,T319-MEF2A CDONCTNNB1 CDH15 CDON p-S139-TCF3 MAPK12 CTNNA2 ATPCTNNB1 MEF2D MYF5 CTNNA1 CTNNB1 CDON CTNNA1 CDH15 p-S139-TCF3 MYF5 MEF2C CTNNB1 p-T180,Y182-MAPK14 BOC-1 ADPCTNNA2 CTNNA2 SPAG9 ADPTCF4 CDON


Description

Myogenesis, the formation of muscle tissue, is a complex process involving steps of cell proliferation mediated by growth factor signaling, cell differentiation, reorganization of cells to form myotubes, and cell fusion. Here, one regulatory feature of this process has been annotated, the signaling cascade initiated by CDO (cell-adhesion-molecule-related/downregulated by oncogenes) and associated co-receptors.

CDO/Cdon is a type I transmembrane multifunctional co-receptor consisting of five immunoglobulin and three fibronectin type III (FNIII) repeats in the extracellular domain, and an intracellular domain with no identifiable motifs. It has been implicated in enhancing muscle differentiation in promyogenic cells. CDO exert its promyogenic effects as a component of multiprotein complexes that include the closely related factor Boc, the Ig superfamily receptor neogenin and its ligand netrin-3, and the adhesion molecules N- and M-cadherin. CDO modulates the Cdc42 and p38 mitogen-activated protein kinase (MAPK) pathways via a direct association with two scaffold-type proteins, JLP and Bnip-2, to regulate activities of myogenic bHLH factors and myogenic differentiation. CDO activates myogenic bHLH factors via enhanced heterodimer formation, most likely by inducing hyper-phosphorylation of E proteins.
Myogenic basic helix-loop-helix (bHLH) proteins are master regulatory proteins that activate the transcription of many muscle-specific genes during myogenesis. These myogenic bHLH proteins also referred to as MyoD family includes four members, MyoD, myogenin, myf5 and MRF4. These myogenic factors dimerize with E-proteins such as E12/E47, ITF-2 and HEB to form heterodimeric complexes that bind to a conserved DNA sequence known as the E box, which is present in the promoters and enhancers of most muscle-specific genes. Myocyte enhancer binding factor 2 (MEF2), which is a member of the MADS box family, also plays an important role in muscle differentiation. MEF2 activates transcription by binding to the consensus sequence, called the MEF2-binding site, which is also found in the control regions of numerous muscle-specific genes. MEF2 and myogenic bHLH proteins synergistically activate expression of muscle-specific genes via protein-protein interactions between DNA-binding domains of these heterologous classes of transcription factors. Members of the MyoD and MEF2 family of transcription factors associate combinatorially to control myoblast specification, differentiation and proliferation. View original pathway at Reactome.</div>

Comments

Reactome-Converter 
Pathway is converted from Reactome ID: 525793
Reactome-version 
Reactome version: 75
Reactome Author 
Reactome Author: Garapati, Phani Vijay

Quality Tags

Ontology Terms

 

Bibliography

View all...
  1. Yang SH, Galanis A, Sharrocks AD.; ''Targeting of p38 mitogen-activated protein kinases to MEF2 transcription factors.''; PubMed Europe PMC Scholia
  2. Zetser A, Gredinger E, Bengal E.; ''p38 mitogen-activated protein kinase pathway promotes skeletal muscle differentiation. Participation of the Mef2c transcription factor.''; PubMed Europe PMC Scholia
  3. Kang JS, Feinleib JL, Knox S, Ketteringham MA, Krauss RS.; ''Promyogenic members of the Ig and cadherin families associate to positively regulate differentiation.''; PubMed Europe PMC Scholia
  4. Lu M, Krauss RS.; ''N-cadherin ligation, but not Sonic hedgehog binding, initiates Cdo-dependent p38alpha/beta MAPK signaling in skeletal myoblasts.''; PubMed Europe PMC Scholia
  5. Wu Z, Woodring PJ, Bhakta KS, Tamura K, Wen F, Feramisco JR, Karin M, Wang JY, Puri PL.; ''p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps.''; PubMed Europe PMC Scholia
  6. Zhao M, New L, Kravchenko VV, Kato Y, Gram H, di Padova F, Olson EN, Ulevitch RJ, Han J.; ''Regulation of the MEF2 family of transcription factors by p38.''; PubMed Europe PMC Scholia
  7. Kang JS, Mulieri PJ, Miller C, Sassoon DA, Krauss RS.; ''CDO, a robo-related cell surface protein that mediates myogenic differentiation.''; PubMed Europe PMC Scholia
  8. Kang JS, Mulieri PJ, Hu Y, Taliana L, Krauss RS.; ''BOC, an Ig superfamily member, associates with CDO to positively regulate myogenic differentiation.''; PubMed Europe PMC Scholia
  9. Krauss RS, Cole F, Gaio U, Takaesu G, Zhang W, Kang JS.; ''Close encounters: regulation of vertebrate skeletal myogenesis by cell-cell contact.''; PubMed Europe PMC Scholia
  10. Wood CD, Thornton TM, Sabio G, Davis RA, Rincon M.; ''Nuclear localization of p38 MAPK in response to DNA damage.''; PubMed Europe PMC Scholia
  11. Blanco-Aparicio C, Torres J, Pulido R.; ''A novel regulatory mechanism of MAP kinases activation and nuclear translocation mediated by PKA and the PTP-SL tyrosine phosphatase.''; PubMed Europe PMC Scholia
  12. Han J, Jiang Y, Li Z, Kravchenko VV, Ulevitch RJ.; ''Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation.''; PubMed Europe PMC Scholia
  13. Black BL, Molkentin JD, Olson EN.; ''Multiple roles for the MyoD basic region in transmission of transcriptional activation signals and interaction with MEF2.''; PubMed Europe PMC Scholia

History

View all...
CompareRevisionActionTimeUserComment
114627view16:08, 25 January 2021ReactomeTeamReactome version 75
113075view11:13, 2 November 2020ReactomeTeamReactome version 74
112310view15:23, 9 October 2020ReactomeTeamReactome version 73
101209view11:10, 1 November 2018ReactomeTeamreactome version 66
100747view20:35, 31 October 2018ReactomeTeamreactome version 65
100291view19:12, 31 October 2018ReactomeTeamreactome version 64
99837view15:56, 31 October 2018ReactomeTeamreactome version 63
99394view14:33, 31 October 2018ReactomeTeamreactome version 62 (2nd attempt)
93765view13:34, 16 August 2017ReactomeTeamreactome version 61
93289view11:19, 9 August 2017ReactomeTeamreactome version 61
88022view13:31, 25 July 2016RyanmillerOntology Term : 'regulatory pathway' added !
86374view09:16, 11 July 2016ReactomeTeamreactome version 56
83197view10:21, 18 November 2015ReactomeTeamVersion54
81576view13:06, 21 August 2015ReactomeTeamVersion53
77038view08:33, 17 July 2014ReactomeTeamFixed remaining interactions
76743view12:10, 16 July 2014ReactomeTeamFixed remaining interactions
76068view10:13, 11 June 2014ReactomeTeamRe-fixing comment source
75778view11:29, 10 June 2014ReactomeTeamReactome 48 Update
75128view14:07, 8 May 2014AnweshaFixing comment source for displaying WikiPathways description
74775view08:51, 30 April 2014ReactomeTeamReactome46
44931view10:57, 6 October 2011MartijnVanIerselOntology Term : 'muscle cell' added !
42083view21:55, 4 March 2011MaintBotAutomatic update
39891view05:55, 21 January 2011MaintBotNew pathway

External references

DataNodes

View all...
NameTypeDatabase referenceComment
ABL1 ProteinP00519 (Uniprot-TrEMBL)
ABL1:JLP:CDO complexComplexR-HSA-449191 (Reactome)
ABL1ProteinP00519 (Uniprot-TrEMBL)
ADPMetaboliteCHEBI:456216 (ChEBI)
ATPMetaboliteCHEBI:30616 (ChEBI)
BNIP2 ProteinQ12982 (Uniprot-TrEMBL)
BNIP2ProteinQ12982 (Uniprot-TrEMBL)
BOC-1 ProteinQ9BWV1-1 (Uniprot-TrEMBL)
BOC-1ProteinQ9BWV1-1 (Uniprot-TrEMBL)
CDC42 ProteinP60953 (Uniprot-TrEMBL)
CDC42:GTPComplexR-HSA-182921 (Reactome)
CDH15 ProteinP55291 (Uniprot-TrEMBL)
CDH2 ProteinP19022 (Uniprot-TrEMBL)
CDH4 ProteinP55283 (Uniprot-TrEMBL)
CDO:BOC:Neogenin:Netrin-3ComplexR-HSA-375091 (Reactome)
CDO:BOC:Trans-cadherin homodimer:cateninComplexR-HSA-375092 (Reactome)
CDO:BOCComplexR-HSA-375094 (Reactome)
CDON ProteinQ4KMG0 (Uniprot-TrEMBL)
CDONProteinQ4KMG0 (Uniprot-TrEMBL)
CTNNA1 ProteinP35221 (Uniprot-TrEMBL)
CTNNA2 ProteinP26232 (Uniprot-TrEMBL)
CTNNB1 ProteinP35222 (Uniprot-TrEMBL)
Cadherin-catenin:CDO:BOC:Bnip2:CDC42-GTPComplexR-HSA-448875 (Reactome)
Cadherin-catenin:CDO:BOC:Bnip2ComplexR-HSA-376008 (Reactome)
Cadherin-catenin:JLP:CDO:BOC:Bnip2-Cdc42ComplexR-HSA-376011 (Reactome)
GTP MetaboliteCHEBI:15996 (ChEBI)
MAPK11 ProteinQ15759 (Uniprot-TrEMBL)
MAPK12 ProteinP53778 (Uniprot-TrEMBL)
MAPK14 ProteinQ16539 (Uniprot-TrEMBL)
MEF2 proteinsComplexR-HSA-448868 (Reactome)
MEF2A ProteinQ02078 (Uniprot-TrEMBL)
MEF2B ProteinQ02080 (Uniprot-TrEMBL)
MEF2C ProteinQ06413 (Uniprot-TrEMBL)
MEF2D ProteinQ14814 (Uniprot-TrEMBL)
MRFsComplexR-HSA-448854 (Reactome)
MYF5 ProteinP13349 (Uniprot-TrEMBL)
MYF6 ProteinP23409 (Uniprot-TrEMBL)
MYOD1 ProteinP15172 (Uniprot-TrEMBL)
MYOG ProteinP15173 (Uniprot-TrEMBL)
MyoD:phospho-E:phospho MEF2ComplexR-HSA-448877 (Reactome)
Myod:phospho-E heterodimersComplexR-HSA-448886 (Reactome)
NEO1 ProteinQ92859 (Uniprot-TrEMBL)
NTN3 ProteinO00634 (Uniprot-TrEMBL)
Netrin-3:NeogeninComplexR-HSA-448880 (Reactome)
SPAG9 ProteinO60271 (Uniprot-TrEMBL)
SPAG9ProteinO60271 (Uniprot-TrEMBL)
TCF12 ProteinQ99081 (Uniprot-TrEMBL)
TCF3ProteinP15923 (Uniprot-TrEMBL)
TCF4 ProteinP15884 (Uniprot-TrEMBL)
Trans-cadherin homodimersComplexR-HSA-448888 (Reactome)
p-S139-TCF3 ProteinP15923 (Uniprot-TrEMBL)
p-S139-TCF3ProteinP15923 (Uniprot-TrEMBL)
p-S207,T211-MAP2K6ProteinP52564 (Uniprot-TrEMBL)
p-T180,Y182-MAPK11 ProteinQ15759 (Uniprot-TrEMBL)
p-T180,Y182-MAPK14 ProteinQ16539 (Uniprot-TrEMBL)
p-T183,Y185-MAPK12 ProteinP53778 (Uniprot-TrEMBL)
p-T293,T300,T387-MEF2C ProteinQ06413 (Uniprot-TrEMBL)
p-T312,T319-MEF2A ProteinQ02078 (Uniprot-TrEMBL)
p38 alpha/beta/gamma:ABL1:JLP:CDO complexComplexR-HSA-448887 (Reactome)
p38 MAPK alpha/beta/gammaComplexR-HSA-448855 (Reactome)
phospho p38:phospho MEF2ComplexR-HSA-448874 (Reactome)
phospho-E proteinsComplexR-HSA-448867 (Reactome)
phospho-MEF2 proteinsComplexR-HSA-448866 (Reactome)
phospho-p38

alpha/beta/gamma

MAPK
ComplexR-HSA-448858 (Reactome)
pp38 alpha/beta/gamma:ABL1:JLP:CDO complexComplexR-HSA-448881 (Reactome)

Annotated Interactions

View all...
SourceTargetTypeDatabase referenceComment
ABL1:JLP:CDO complexArrowR-HSA-448958 (Reactome)
ABL1:JLP:CDO complexArrowR-HSA-449200 (Reactome)
ABL1:JLP:CDO complexR-HSA-448957 (Reactome)
ABL1R-HSA-449200 (Reactome)
ADPArrowR-HSA-448948 (Reactome)
ADPArrowR-HSA-448951 (Reactome)
ADPArrowR-HSA-448955 (Reactome)
ATPR-HSA-448948 (Reactome)
ATPR-HSA-448951 (Reactome)
ATPR-HSA-448955 (Reactome)
BNIP2R-HSA-376121 (Reactome)
BOC-1R-HSA-375138 (Reactome)
CDC42:GTPR-HSA-376119 (Reactome)
CDO:BOC:Neogenin:Netrin-3ArrowR-HSA-375141 (Reactome)
CDO:BOC:Trans-cadherin homodimer:cateninArrowR-HSA-375140 (Reactome)
CDO:BOC:Trans-cadherin homodimer:cateninR-HSA-376121 (Reactome)
CDO:BOCArrowR-HSA-375138 (Reactome)
CDO:BOCR-HSA-375140 (Reactome)
CDO:BOCR-HSA-375141 (Reactome)
CDONR-HSA-375138 (Reactome)
Cadherin-catenin:CDO:BOC:Bnip2:CDC42-GTPArrowR-HSA-376119 (Reactome)
Cadherin-catenin:CDO:BOC:Bnip2:CDC42-GTPR-HSA-376117 (Reactome)
Cadherin-catenin:CDO:BOC:Bnip2ArrowR-HSA-376121 (Reactome)
Cadherin-catenin:CDO:BOC:Bnip2R-HSA-376119 (Reactome)
Cadherin-catenin:JLP:CDO:BOC:Bnip2-Cdc42ArrowR-HSA-376117 (Reactome)
Cadherin-catenin:JLP:CDO:BOC:Bnip2-Cdc42R-HSA-449200 (Reactome)
MEF2 proteinsR-HSA-448955 (Reactome)
MRFsR-HSA-448962 (Reactome)
MyoD:phospho-E:phospho MEF2ArrowR-HSA-448963 (Reactome)
Myod:phospho-E heterodimersArrowR-HSA-448962 (Reactome)
Myod:phospho-E heterodimersR-HSA-448963 (Reactome)
Netrin-3:NeogeninR-HSA-375141 (Reactome)
R-HSA-375138 (Reactome) CDO and BOC form complexes in a cis fashion via association of both their ectodomains and their intracellular domains. CDO and BOC exert their effects as components of a receptor, in which the role of BOC is primarily extracellular and that of CDO includes intracellular signaling.
R-HSA-375140 (Reactome) In myoblasts, CDO forms cis complexes with the cell–cell adhesion molecule N-cadherin, which is itself involved in regulation of myogenesis. These cadherin complexes contain beta- and alpha-catenins which are important for N-cadherin's effect in myoblast. When CDO binds with ligated cadherins, its intracellular region undergoes a change in conformation and/or posttranslational modi?cation that permits its stable association with Bnip-2 and JLP and, consequently, activation of p38.
R-HSA-375141 (Reactome) CDO selectively binds to neogenin in a cis fashion and this interaction involves extracellular domains of both proteins. CDO is essential in mediating netrin-3-induced differentiation of myoblasts by neogenin. Neogenin and netrin-3 stimulate myotube formation and enhance myogenic bHLH-and NFAT-dependent transcription.
R-HSA-376117 (Reactome) JLP is a scaffold protein for the p38 MAPK pathway. During myogenic differentiation JLP binds the intracellular region of CDO which in turn binds p38 leading to p38 activation. The major CDO-binding region of JLP resides between amino acids 465-647.
R-HSA-376119 (Reactome) Bnip-2 interacts with Cdc42 through its Bnip-2 and Cdc42GAP homology (BCH) domain and thus it acts as a linkage between the CDO receptor and the Cdc42 activity. Formation of a CDO-Bnip-2-Cdc42 complex stimulates Cdc42 activation which in turn promotes p38 alpha/beta activity and cell differentiation.
R-HSA-376121 (Reactome) Bnip-2 is a scaffold protein with a single recognizable motif, a BCH domain that spans its C-terminal half involved in the dynamic regulation of Cdc42 signaling. The CDO intracellular region binds Bnip-2 and this complex regulates Cdc42 activity.
R-HSA-448948 (Reactome) p38 MAPK plays a fundamental role in the transition of myoblasts to different myocytes. Activated p38 MAPK phosphorylates E12/E47, a member of the E protein subfamily of bHLH proteins. p38 MAPK in particular phosphorylates Ser140 of E47. Its been observed that phosphorylation of E47 improves its ability to form heterodimers with Myod transcription factor.
R-HSA-448951 (Reactome) p38 alpha/beta MAPK is well established as a promyogenic kinase, but the mechanism by which it is activated during differentiation is not well understood. CDO, JLP and p38 form a ternary complex and it is anticipated that in its role as a scaffold, JLP brings additional components of the pathway, such as MKKs, to these complexes and cooperate to activate p38 alpha/beta MAPK pathway. p38 is activated by phosphorylation on a canonical TxY motif by dual specificity kinases MKK6 and MKK3. MKK6 is the most abundant in skeletal muscles and displays minimal substrate selectivity among all p38 isoforms.
R-HSA-448955 (Reactome) The family of transcription factors myocyte enhancer factor-2 (MEF2) regulate myogenesis through combinatorial interactions with other transcription factors to the MEF2 site found in the promoter regions of numerous muscle specific genes. There are four members of the MEF2 family, MEF2A to D.
p38 MAPK plays a role in the regulation of the MEF2 family members and this is mediated by the phosphorylation of two or three (Thr312 and 319 in MEF2A and Thr 293, 300 and ser387 in MEF2C) amino acids in the C-terminal activation domain of MEF2 factors. MEF2A and MEF2C are preferred substrates for p38 compared with MEF2B and MEF2D. The phosphorylation of MEF2 members results in their increased transcriptional activity.
R-HSA-448957 (Reactome) JLP is a p38 alpha/beta MAPK scaffold protein. p38 alpha/beta MAPK binds to two sites within JLP (amino acids 1-110 and 160-209), neither of which overlaps the CDO binding region.
R-HSA-448958 (Reactome) p38 MAPK is activated by phosphorylation in response to CDO-BOC interactions. Activated p38 MAPK may translocate into the nucleus to further activate myogenic related transcription factors.
R-HSA-448962 (Reactome) MyoD is a basic helix loop helix (bHLH) myoblast specific transcription factor defined as a 'master switch' gene in that it can convert other cell types into muscles if the gene is active in them. bHLH proteins Myf5, Myogenin and MRF4/Myf6 are highly related to MyoD and these along with MyoD form the 'MyoD family' of transcription factors, also called the myogenic regulatory factors (MRFs).
MRFs form transcriptionally active heterodimers with the widely expressed E proteins, a distinct group of bHLH proteins including E12/E47, ITF-2 and HEB. Dimerization of these proteins juxtaposes their basic domains forming a functional DNA binding domain. MyoD/E protein heterodimers preferentially bind the DNA consensus sequence referred to as an E-box (CANNTG) in the control regions of muscle-specific genes and activate gene transcription of genes that are expressed in skeletal muscle.
R-HSA-448963 (Reactome) MyoD-E protein heterodimers interact with MEF2 proteins to synergistically activate myogenesis. This interaction occurs via association of these two heterologous classes of transcription factors through their DNA-binding and dimerization motifs. The combinatorial associations of these two protein families appear to establish a transcriptional code specific for skeletal muscle gene activation. Together with the Mef2 proteins and E proteins, MyoD transcription factors are responsible for coordinating muscle-specific gene expression in the undifferentiated myoblast. MyoD activation leads to expression of myogenin, M-cadherin, myosin heavy and light chains, and muscle creatine kinase.
R-HSA-449200 (Reactome) ABL binds to the cytoplasmic tail of CDO and also to the p38 MAPK scaffold protein JLP. ABL binds a proline-rich motif in CDO via its SH3 domain, and ABL is necessary for full activation of p38 MAPK, during myogenic differentiation.
SPAG9R-HSA-376117 (Reactome)
TCF3R-HSA-448948 (Reactome)
Trans-cadherin homodimersR-HSA-375140 (Reactome)
p-S139-TCF3ArrowR-HSA-448948 (Reactome)
p-S207,T211-MAP2K6mim-catalysisR-HSA-448951 (Reactome)
p38 alpha/beta/gamma:ABL1:JLP:CDO complexArrowR-HSA-448957 (Reactome)
p38 alpha/beta/gamma:ABL1:JLP:CDO complexR-HSA-448951 (Reactome)
p38 MAPK alpha/beta/gammaR-HSA-448957 (Reactome)
phospho p38:phospho MEF2ArrowR-HSA-448955 (Reactome)
phospho-E proteinsR-HSA-448962 (Reactome)
phospho-MEF2 proteinsR-HSA-448963 (Reactome)
phospho-p38

alpha/beta/gamma

MAPK
ArrowR-HSA-448958 (Reactome)
phospho-p38

alpha/beta/gamma

MAPK
R-HSA-448955 (Reactome)
phospho-p38

alpha/beta/gamma

MAPK
mim-catalysisR-HSA-448948 (Reactome)
phospho-p38

alpha/beta/gamma

MAPK
mim-catalysisR-HSA-448955 (Reactome)
pp38 alpha/beta/gamma:ABL1:JLP:CDO complexArrowR-HSA-448951 (Reactome)
pp38 alpha/beta/gamma:ABL1:JLP:CDO complexR-HSA-448958 (Reactome)

Personal tools